TrialJournal of inflammation research2021

Proprotein Convertase Subtilisin/Kexin Type 9 and Systemic Inflammatory Biomarker Pentraxin 3 for Risk Stratification Among STEMI Patients Undergoing Primary PCI.

Xiaoxiao Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.